{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:11:49Z","timestamp":1793250709344,"version":"4.5.0"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":117,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>We investigated whether the early favourable effects of combined GLP-1 receptor agonist (GLP-1RA) and SGLT2 inhibitor (SGLT2i) therapy in left ventricular deformation is associated with long-term cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM). We also addressed the healthcare costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We enrolled 336 consecutive participants with T2DM, aged 60 \u00b1 10 years old, 252\/336 (75%) were males and were categorized into four groups: insulin, liraglutide, empagliflozin, and liraglutide+ empagliflozin. We measured at baseline and at 6 months left ventricular global longitudinal strain (LVGLS) via echocardiography. Patients were followed for 6 years and we recorded the incidence of composite endpoint of non-fatal cardiovascular events (myocardial infarction, heart failure hospitalization, ischaemic stroke, and coronary revascularization). Multivariable Cox regression models were built to assess associations between treatment groups, LVGLS changes, and outcomes. A cost analysis was also conducted. At 6 months LVGLS increased significantly (P = 0.020), with the greatest improvement observed in the combination group compared with insulin, GLP-1RA, and SGLT2i groups (P &amp;lt; 0.05). At 6-year follow-up, 91 events were recorded. Combination therapy was associated with the lowest risk of events (insulin vs. combination: HR = 4.36, 95% CI: 2.04\u20139.33, P &amp;lt; 0.001; GLP1-RA vs. combination: HR = 2.45, 95% CI: 1.06\u20135.64, P = 0.035; SGLT2i vs. combination: HR = 3.07, 95% CI: 1.38\u20136.81, P = 0.006). In combination group, improvement of LVGLS independently predicted reduced event risk (HR = 0.89, 95% CI: 0.79\u20130.98, P = 0.040). Combination group demonstrated the lowest mean cost per patient per month (insulin: 691\u20ac, 95% CI: 472\u2013911; GLP1-RA: 224\u20ac, 95% CI: 44\u2013404; SGLT2i: 528\u20ac, 95% CI: 305\u2013751; Combination: 175\u20ac, 95% CI: 30\u2013321).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Combined GLP-1RA and SGLT2i therapy is associated with early improvement in myocardial deformation, which translates into reduced long-term cardiovascular risk and favourable economic outcomes.<\/jats:p>\n                    <jats:p>ClinicalTrials.gov Identifier: NCT03878706<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjimp\/qyag080","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:44:26Z","timestamp":1777031066000},"source":"Crossref","is-referenced-by-count":1,"title":["Myocardial deformation links combined liraglutide\u2013empagliflozin therapy with improved cardiovascular and economic outcomes in type 2 diabetes: a 6-year study"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3916-5350","authenticated-orcid":false,"given":"John","family":"Thymis","sequence":"first","affiliation":[{"name":"2nd Cardiology Department, National & Kapodistrian University of Athens, Attikon University Hospital , Rimini 1, Chaidari, 124 62 Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigoris","family":"Oikonomidis","sequence":"additional","affiliation":[{"name":"2nd Cardiology Department, National & Kapodistrian University of Athens, Attikon University Hospital , Rimini 1, Chaidari, 124 62 Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Georgiopoulos","sequence":"additional","affiliation":[{"name":"2nd Cardiology Department, National & Kapodistrian University of Athens, Attikon University Hospital , Rimini 1, Chaidari, 124 62 Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Pavlidis","sequence":"additional","affiliation":[{"name":"2nd Cardiology Department, National & Kapodistrian University of Athens, Attikon University Hospital , Rimini 1, Chaidari, 124 62 Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Kourassis","sequence":"additional","affiliation":[{"name":"2nd Cardiology Department, National & Kapodistrian University of Athens, Attikon University Hospital , Rimini 1, Chaidari, 124 62 Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Katsanaki","sequence":"additional","affiliation":[{"name":"2nd Cardiology Department, National & Kapodistrian University of Athens, Attikon University Hospital , Rimini 1, Chaidari, 124 62 Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Vlachomitros","sequence":"additional","affiliation":[{"name":"2nd Cardiology Department, National & Kapodistrian University of Athens, Attikon University Hospital , Rimini 1, Chaidari, 124 62 Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1732-2255","authenticated-orcid":false,"given":"Gavriella","family":"Kostelli","sequence":"additional","affiliation":[{"name":"2nd Cardiology Department, National & Kapodistrian University of Athens, Attikon University Hospital , Rimini 1, Chaidari, 124 62 Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4620-4039","authenticated-orcid":false,"given":"Vaia","family":"Lambadiari","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Research Unit and Diabetes Center, National & Kapodistrian University of Athens, Attikon University Hospital , Rimini 1, Chaidari, 124 62 Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8241-7886","authenticated-orcid":false,"given":"Ignatios","family":"Ikonomidis","sequence":"additional","affiliation":[{"name":"2nd Cardiology Department, National & Kapodistrian University of Athens, Attikon University Hospital , Rimini 1, Chaidari, 124 62 Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"2026053114414371700_qyag080-B1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.039129","article-title":"Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and their combination on neurohumoral and mitochondrial activation in patients with diabetes","volume":"14","author":"Ikonomidis","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026053114414371700_qyag080-B2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005521","article-title":"Global longitudinal strain by echocardiography predicts long-term risk of cardiovascular morbidity and mortality in a low-risk general population: the Copenhagen City Heart Study","volume":"10","author":"Biering-S\u00f8rensen","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026053114414371700_qyag080-B3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015716","article-title":"Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and their combination on endothelial glycocalyx, arterial function, and myocardial work index in patients with type 2 diabetes mellitus after 12-month treatment","volume":"9","author":"Ikonomidis","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026053114414371700_qyag080-B4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12933-023-02118-6","article-title":"GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes","volume":"23","author":"Marfella","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"2026053114414371700_qyag080-B5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12933-022-01618-1","article-title":"Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial","volume":"21","author":"Nesti","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2026053114414371700_qyag080-B6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ejhf.1436","article-title":"The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association","volume":"21","author":"Ikonomidis","year":"2019","journal-title":"Eur J Heart Fail"}],"container-title":["European Heart Journal - Imaging Methods and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjimp\/advance-article-pdf\/doi\/10.1093\/ehjimp\/qyag080\/68173358\/qyag080.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjimp\/article-pdf\/4\/1\/qyag080\/68173358\/qyag080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjimp\/article-pdf\/4\/1\/qyag080\/68173358\/qyag080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T18:41:48Z","timestamp":1780252908000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjimp\/article\/doi\/10.1093\/ehjimp\/qyag080\/8663809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjimp\/qyag080","relation":{},"ISSN":["2755-9637"],"issn-type":[{"value":"2755-9637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1,1]]},"article-number":"qyag080"}}